US DRUGMAKER Pfizer, the world's dominant Covid vaccine maker, has been accused of funding educational presentations that said its UK rival AstraZeneca was ineffective and even dangerous for some members of the population.
A Channel 4 Dispatches investigation, due to be broadcast this week, said it had "uncovered evidence" that Pfizer funded a number of educational presentations that were delivered to health professionals across Canada about its mRNA vaccine.
Included in these presentations were slides that listed several disadvantages of the "viral vector" technology that is the basis for the AstraZeneca vaccine, the broadcaster said.
Delivered by speakers who had received funds from Pfizer, the slides said there is a risk of "chromosomal in- tegration and oncogenesis" with such vaccines, which suggests they might turn a healthy cell into a cancerous cell. They also claimed that the AstraZeneca vaccine cannot be used in immunocompromised people.
The claims made about the viral vector vaccine's disadvantages originated from a scientific paper written by a group of authors, one of whom had worked for several years on Pfizer jabs.
Channel 4 Dispatches did not say where it had found the evidence for these claims, and Pfizer denied it "sought to undermine others' scientific endeavours".
Professor Sir Andrew Pollard, part of the Oxford group that developed the AstraZeneca vaccine, said there was "absolutely zero evidence" that the vaccine "would or could" cause cancer, and that it had been given to millions of immunocompromised people and caused no harm.
(c) 2021 City A.M., source Newspaper